Literature DB >> 10482637

Localization of a passively transferred human recombinant monoclonal antibody to herpes simplex virus glycoprotein D to infected nerve fibers and sensory neurons in vivo.

P P Sanna1, T J Deerinck, M H Ellisman.   

Abstract

A human recombinant monoclonal antibody to herpes simplex virus (HSV) glycoprotein D labeled with the fluorescent dye Cy5 was administered to mice infected in the cornea with HSV type 1 (HSV-1). The distribution of such antibody in the corneas and trigeminal ganglia of the mice was then investigated by confocal microscopy. The antibody was detected on HSV-infected nerve fibers in the cornea--identified by colocalization with HSV antigens and the neuritic markers neurofilament, GAP-43, synapsin-1, and CNPase--and on the perikarya of sensory neurons in the HSV-1-infected neurons in ipsilateral trigeminal ganglia. Antibodies have been shown to be effective against many neurotropic viruses, often in the absence of obvious cell damage. Observations from experimental HSV infections suggest that antibodies could act in part by interfering with virus expression in the ganglia and/or with axonal spread. The present results provide morphological evidence of the localization of antiviral antibodies at anatomical sites relevant to such putative antibody-mediated protective actions and suggest that viral glycoproteins are accessible to antibodies on infected nerve fibers and sensory neurons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482637      PMCID: PMC112904          DOI: 10.1128/JVI.73.10.8817-8823.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly.

Authors:  M E Penfold; P Armati; A L Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

2.  Distribution and ontogeny of parvalbumin immunoreactivity in the chicken retina.

Authors:  P P Sanna; K T Keyser; T J Deerink; M H Ellisman; H J Karten; F E Bloom
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

3.  Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes.

Authors:  A M Eis-Hübinger; D S Schmidt; K E Schneweis
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

4.  Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis.

Authors:  K L Tyler; M A Mann; B N Fields; H W Virgin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.

Authors:  Z Mikloska; P P Sanna; A L Cunningham
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

7.  Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Authors:  R Burioni; R A Williamson; P P Sanna; F E Bloom; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.

Authors:  M H Ritchie; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-07       Impact factor: 4.799

9.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection.

Authors:  Y H Su; X T Yan; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Teratogenic effects of neonatal arenavirus infection on the developing rat cerebellum are abrogated by passive immunotherapy.

Authors:  J R Baldridge; B D Pearce; B S Parekh; M J Buchmeier
Journal:  Virology       Date:  1993-12       Impact factor: 3.616

View more
  7 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application.

Authors:  Marianne Berdugo; Inna V Larsen; Claire Abadie; Catherine Deloche; Laura Kowalczuk; Elodie Touchard; Richard Dubielzig; Curtis R Brandt; Francine Behar-Cohen; Jean-Marc Combette
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

3.  Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.

Authors:  Adalbert Krawczyk; Jürgen Krauss; Anna M Eis-Hübinger; Martin P Däumer; Robert Schwarzenbacher; Ulf Dittmer; Karl E Schneweis; Dirk Jäger; Michael Roggendorf; Michaela A E Arndt
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection.

Authors:  C Shimeld; S Efstathiou; T Hill
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2.

Authors:  Gregg N Milligan; Michael G Meador; Chin-Fun Chu; Christal G Young; Talitha L Martin; Nigel Bourne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Chin-Fun Chu; Michael G Meador; Christal G Young; Jane E Strasser; Nigel Bourne; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2007-10-24       Impact factor: 4.054

7.  Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.

Authors:  Adalbert Krawczyk; Miriam Dirks; Maren Kasper; Anna Buch; Ulf Dittmer; Bernd Giebel; Lena Wildschütz; Martin Busch; Andre Goergens; Karl E Schneweis; Anna M Eis-Hübinger; Beate Sodeik; Arnd Heiligenhaus; Michael Roggendorf; Dirk Bauer
Journal:  PLoS One       Date:  2015-01-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.